Biosimilars Archives

Biosimilars

September 22, 2023

Survey Reveals Adalimumab-atto Maintains Leadership in US Adalimumab Biosimilars Market

Spherix Global Insights, a leading provider of market research, conducted a survey using a sample of 81 rheumatologists, 83 gastroenterologists,...

September 14, 2023

Amgen’s Amjevita Remains the Frontrunner in the US Adalimumab Biosimilars Market, Despite Increased Competition, According to Spherix Global Insights.

Boehringer Ingelheim’s Cyltezo has a slight competitive edge over other concurrent biosimilar launches on certain key performance metrics, though prescriber...

June 07, 2023

BiosimilarsPress Release

Don’t Mess with Success: U.S. Immunology Treaters Resistant to Switching Stable Humira Patients to Biosimilars, According to Spherix Global Insights

Adalimumab biosimilars hold potential to grow the overall biologic-treated population, but only if the cost savings translate to patients and...

February 06, 2023

BiosimilarsPress Release

Spherix Global Insights Announces Special Coverage of Amgen’s Amjevita Launch, Tracking Uptake and Perceptions of the First Commercially-available Biosimilar to AbbVie’s Humira

According to a survey of autoimmune specialists, in the first week of launch, aided awareness of Amjevita is high, but...